BELKYRA TM (deoxycholic acid) injection
Many people have the need to eliminate fat to get a smoother and more beautiful face or body line. Non-surgical fat elimination methods are the first choice for many people because of their lower risk and shorter recovery period. In 2018, BELKYRA® (BELKYRA™), the only injection approved by the US Food and Drug Administration (FDA) to improve double chin fat, was officially launched in Taiwan.
BELKYRA® (deoxycholic acid) injection is a prescription drug that is a clear, colorless, sterile solution suitable for injection into the subcutaneous area. The injection contains the cell-lytic agent deoxycholic acid (this is the active ingredient) to improve the appearance and contour of moderate to severe accumulation of fat under the chin (i.e., submental fat) in adults (commonly known as double chin). Clinically verified, generally after 2-3 bottles at a time, 2-4 courses of treatment, 79% of people will be satisfied with the results, and 68.2% of patients have at least 1 grade reduction in submental fat (double chin fat).
Nicknamed "slap needle", BELKYRA® (Bekzhi™) was officially approved by the US FDA on April 29, 2015. It has been widely and safely used in the United States, Europe, Canada, and Australia to improve double chin fat. It is a non-surgical and non-invasive double chin fat-reducing injection. Taiwan was officially approved by the Ministry of Health and Welfare on April 28, 2017, and it is the first region in Asia to be listed.
BELKYRA® mechanism of action is converted into a cell-lytic drug. When the drug is injected into the tissue, it will cause physical damage to the cell membrane and cause the cell to dissolve. Endogenous deoxycholic acid is a product of cholesterol metabolism and will be excreted intact through feces. Under normal circumstances, the metabolism of deoxycholic acid is not significant. The deoxycholic acid in BELKYRA® is added to the endogenous bile acid pool in the enterohepatic circulation and is excreted and metabolized along with the endogenous deoxycholic acid.
Applicable areas and groups
Belkyra is currently the only legal double chin fat-reducing injection (commonly known as palm injection) in the United States and Taiwan. It is suitable for people who self-assess that the submental contour features are not ideal.
Three special advantages of Belkyra fat-removing injection
Advantage 1: No need for surgery, easy fat removal with minimal wounds
Belkyra fat-removing injection has passed the indications approved by the US FDA and uses a new safe and non-invasive method to eliminate excess fat on the chin. No surgery, no surgical risks, no anesthesia, only a tiny needle hole size can eliminate unwanted fat cells.
Advantage 2: Long-lasting effect, fat removal without regeneration
Belkyra Belkyra will not regenerate fat cells and the effect is long-lasting. Korean professional doctors remind that new fat cells may still increase due to rapid weight gain, so you should maintain your weight and a healthy lifestyle to ensure that the improved effect is sustained without repeated treatment.
Advantage 3: Remove obesity and improve loose skin at the same time
In addition to removing excess fat, Belkyra also stimulates the activation of fibroblasts and collagen proliferation during the process of fat destruction, thereby enhancing the support of fiber intervals in the skin and skin elasticity, and improving the firmness of the skin on the chin and neck.
Ideal submental features
1. Prominent jawline
2. Subhyoid depression
3. Visible thyroid cartilage protrusion
4. Visible sternocleidomastoid muscle
5. Chin neck angle
6. 90-degree submental angle of sternocleidomastoid muscle (SM-SM angle)
7. Submental gland
Audited Supplier 
){kind=link}